Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Senology Newsletter - November 6, 2014


Published on

Latest Advances in Clinical Senology and Oncology

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Senology Newsletter - November 6, 2014

  1. 1. - Newsletter International Senologic and Oncologic Scientific Community (ISOSC) "Connecting specialists worldwide" November 6, 2014 Editor-in-Chief: Gian Paolo Andreolet t i, MD Senology apps for iPad, iPhone, and Android tablets now available, to provide anytime, anywhere access to Senology contents Join us on LinkedIn, Twitter, Facebook, YouTube, ResearchGate, SlideShare, Flickr, and share comments. Read Senology Newspaper daily Senology collaborates with conve rte d by W e b2PDFC onve
  2. 2. Literature Selection Stanec Z et al.: "Skin and nipple-areola complex sparing mastectomy in breast cancer patients: 15-year experience", Ann Plast Surg. 2014 Nov;73(5):485-91 Warnberg F et al.: "Effect of Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma in Situ: 20 Years Follow-Up in the Randomized SweDCIS Trial", J Clin Oncol. 2014 Oct 13. pii: JCO.2014.56.2595. [Epub ahead of print] Ko DH et al.: "Hypofractionated radiation treatment following mastectomy in early breast cancer: The Christchurch experience", J Med Imaging Radiat Oncol. 2014 Oct 6 [Epub ahead of print] Mast ME et al.: "Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients", Breast Cancer Res Treat. 2014 Nov;148(1):33-9 Perez EA et al.: "Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831", J Clin Oncol. 2014 Oct 20 [Epub ahead of print] Araki K et al.: "Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer", Breast Cancer Res Treat. 2014 Nov;148(1):197-209 Derry HM et al.: "Yoga and self-reported cognitive problems in breast cancer survivors: a randomized controlled trial", Psychooncology. 2014 Oct 21 [Epub ahead of print] Editorial "Timing of breast reconstruction and radiotherapy" - Liesbeth Boersma, Maastricht University Medical Center, Maastricht, The Netherlands Calendar of Events 10th Meet the Professor. Advanced International Breast Cancer Conference (AIBCC), November 6-8 2014, Padua, Italy - under the Patronage of Senology 2nd Breast Cancer in Young Women Conference (BCY2), 6-7 November 2014, Tel Aviv, Israel Late and later relapses and sequelae: the dilemma of endocrine treatment duration, compliance and treatment tailoring, November 7 2014, Milan, Italy Literature Selection J Ji et al.: "Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden", Br J Cancer. 2014 Oct 14 [Epub ahead of print] Jones LW et al.: "Exercise and Risk of Major Cardiovascular Events in Adult Survivors of Childhood Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study", J Clin Oncol. 2014 Oct 13. pii: JCO.2014.56.7511. [Epub ahead of print] van Nimwegen FA et al.: "Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma", J Clin Oncol. 2014 Oct 10;32(29):3257-63 Rossi A et al.: "Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small- cell lung cancer: a systematic review and meta-analysis of individual patient data", Lancet Oncol. 2014 Oct;15(11):1254-62 Bell N et al.: "Recommendations on screening for prostate cancer with the prostate-specific antigen test", CMAJ. 2014 Oct 27. pii: cmaj.140703. [Epub ahead of print] Literature Selection Gourlay ML et al.: "Baseline age and time to major fracture in younger postmenopausal women", Menopause. 2014 Oct 27. [Epub ahead of print] conve rte d by W e b2PDFC onve
  3. 3. Subscribe Unsubscribe Contact Back Issues Newsletter conve rte d by W e b2PDFC onve